Estratégias empresariais de base territorial: o caso Symington e a produção de vinho do Porto

Autor: José Cadima Ribeiro, José Freitas Santos

Publikováno v: DRd - Desenvolvimento Regional em debate. 2:134-155

Numa época em que as fronteiras físicas se esbatem e os negócios assumem uma natureza cada vez mais global, não são raros os casos de empresas que partindo de uma base regional limitada conseguiram impor-se nos mercados internacionais. O uso de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5222775b07f1f0f07ee608cf8917a0a3
https://doi.org/10.24302/drd.v2i1.86

Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.

Autor: O'Connell N; National Coagulation Centre, St. James's Hospital, Dublin, Ireland; School of Medicine, Trinity College, Dublin, Ireland. Electronic address: noconnell@stjames.ie., van der Valk P; Van Creveldkliniek, Department of Benign Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Le Quellec S; CSL Behring, King of Prussia, Pennsylvania, USA., Gomez E; The Center for Inherited Blood Disorders, Orange, California, USA., Monahan PE; CSL Behring, King of Prussia, Pennsylvania, USA., Crary SE; Department of Pediatrics, Hematology and Oncology, Arkansas Children's Hospital, Little Rock, Arkansas, USA., Coppens M; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands., Lemons R; Pediatric Hematology-Oncology, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA., Castaman G; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy., Klamroth R; Internal Medicine - Angiology and Hemostaseology, Vivantes Klinikum, Berlin, Germany., Symington E; Cambridge University Hospitals, Cambridge, United Kingdom., Quon DV; Orthopaedic Hemophilia Treatment Center, Los Angeles, California, USA., Kampmann P; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.

Autor: Madan B; Centre for Haemostasis and Thrombosis, Guy's and St Thomas' National Health Service Trust, London, United Kingdom. Electronic address: Bella.Madan@gstt.nhs.uk., Ozelo MC; Hemocentro University of Campinas, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil., Raheja P; Haemophilia Centre, Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom., Symington E; Haemophilia Centre, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom., Quon DV; Orthopaedic Hemophilia Treatment Center, Los Angeles, California, USA., Leavitt AD; Hemophilia Treatment Center, University of California San Francisco, San Francisco, California, USA., Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA., Lowe G; West Midlands Adult Haemophilia Comprehensive Care Centre, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, United Kingdom., Kenet G; The National Hemophilia Center and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel HaShomer, Tel Aviv University, Tel Aviv, Israel., Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota, Minneapolis, Minnesota, USA., Mason J; Queensland Haemophilia Centre, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; School of Medicine, University of Queensland, Brisbane, Queensland, Australia., Wang M; Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., von Drygalski A; Department of Medicine, University of California San Diego, La Jolla, California, USA., Klamroth R; Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Berlin, Germany; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany., Shapiro S; Blood Theme Oxford Biomedical Research Centre, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom; Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Oxford National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom., Chambost H; AP-HM, Department of Pediatric Hematology Oncology, Children Hospital La Timone & Aix Marseille University, Institut national de la santé et de la recherche médicale, Institut national de la recherche agronomique, Centre recherche en CardioVasculaire et Nutrition, Marseille, France., Dunn AL; The Division of Hematology, Oncology, and Blood and Marrow Transplantation at Nationwide Children's Hospital and Ohio State University College of Medicine, The Ohio State University, Columbus, Ohio, USA., Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine and Center for Rare Diseases, University Hospital Bonn, Bonn, Germany., Chou SC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Millar CM; Centre for Haematology, Imperial College London, London, United Kingdom; Imperial College Healthcare National Health Service Trust, London, United Kingdom., Osmond D; BioMarin Pharmaceutical Inc, Novato, California, USA., Yu H; BioMarin Pharmaceutical Inc, Novato, California, USA., Dashiell-Aje E; BioMarin Pharmaceutical Inc, Novato, California, USA., Robinson TM; BioMarin Pharmaceutical Inc, Novato, California, USA., Mahlangu J; Hemophilia Comprehensive Care Center, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Jul; Vol. 22 (7), pp. 1880-1893. Date of Electronic Publication: 2024 Apr 12.

Oh! My Heart (Herz, mein Herz) J. W. Symington E. A. Sydenham

Publikováno v: The Musical Times and Singing Class Circular, 1870 May 01. 14(327), 468-468.

Externí odkaz: https://www.jstor.org/stable/3355061

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.